Search

To understand the relationship among easterly waves, tropical cyclones ( TCs), and the large-scale environment, a robust climatology of easterly waves for the tropical Western Hemisphere has been developed. The foundation for the climatology is a new easterly wave tracking algorithm that identifies westwards propagating disturbances over the tropical East Pacific, Atlantic, and Africa. To assess the issue of track dependencies and easterly wave representation, climatologies are prepared separately from the NCEP- NCAR, CFS-R, ERA-40, and ERA-Interim reanalyses. The source code for the easterly wave-tracking algorithm along with the easterly wave climatology for each atmospheric reanalysis is publicly available from NOAA's National Centers for Environmental Information. [ABSTRACT FROM AUTHOR]

An abstract of the article "Dopamine transporter single nucleotide polymorphisms (SNPs) in Belgian Malinois dogs," by L. Lit and colleagues is presented.

mTOR inhibitors exert a preventive effect on cytomegalovirus (CMV) disease in CMV seropositive (R+) kidney transplant recipients, but their impact during the curative treatment of CMV disease in high-risk kidney transplant recipients has not been investigated. We aimed to evaluate the efficacy and tolerance of mTOR inhibitors compared with mycophenolic acid in 63 consecutive kidney transplant recipients (80% of D+R-) suffering from CMV disease with a persistent or a recurrent CMV DNAemia. In this monocentric retrospective study, 16 had their treatment converted to mTOR inhibitors and 47 did not. The Kaplan-Meier curves did not show any significant differences in CMV DNAemia eradication (77% vs. 88% respectively; hazard ratio (HR), 1.648 [95% confidence interval (CI), 0.913-2.973]; log-rank test, P = .132), DNAemia recurrence (36% vs. 47%; HR, 1.517 [95% CI, 0.574-4.007]; log-rank test, P = .448) and CMV clinical recurrence (17% vs. 27%; HR, 1.375 [95% CI, 0.340-5.552]; log-rank test, P = .677) between patients who received mTOR inhibitors and those who did not. These results were confirmed in uni- and multivariate time-dependent Cox regressions. In summary, conversion from mycophenolic acid to mTOR inhibitors seems inadequate for improving CMV clearance or in better preventing CMV recurrences during severe or persistent CMV disease., (© 2020 The Societies and John Wiley & Sons Australia, Ltd.)